free simple website templates

PharmaSolv Consulting

Pharmaceutical Solutions From Discovery Through Development

Helping you improve the druggability and formulability of your drug compound


What Can PharmaSolv Consulting Do For You?


Select the right form/phase of the API

• What salt form of the drug substance or active pharmaceutical ingredient should I choose?
• Does my salt disproportionate in the formulation (solution, suspensions, parenteral formulations, solid oral dosage forms…)?
• What polymorph?
• Should I select an amorphous phase?


Select the right preclinical safety toxicology formulation

• What formulation should I select to maximize exposures?
• What vehicle should be used when dosing rodents/non-rodents orally, parenterally (injectable)?


Maximize bioavailability

• What formulation should be used in pre-clinical tox studies?
• Can formulation solve my exposure issues?
• Can changing the form of the drug compound help?



• How can I maximize plasma exposures?
• How can I reduce variability in plasma exposures?
• What is happening to the drug substance during formulation development?
• What excipients should I avoid in my formulations?
• Why do the plasma concentrations decrease?
• Does my API crystallize from the amorphous solid dispersion formulations?
• Does it convert to a new polymorph?
• Does the salt disproportionate in the dosage form?